K Calleweart

No ORCID on file · 1 paper in corpus

nonrandomized-trial 2003

Endometrial safety with a low-dose intrauterine levonorgestrel-releasing system after 3 years of estrogen substitution therapy

Maturitas ·doi:10.1016/j.maturitas.2003.07.002

OBJECTIVE: To evaluate the pharmacodynamic effects of a novel intrauterine drug delivery system, FibroPlant-levonorgestrel (LNG), on the endometrium in 24 postmenopausal women using estrogen substitution therapy (EST) to suppress climacteri…